CCX-354

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameCCX-354
Drug Alias NameCCX-354CCX-354-CGSK-2941266
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 1 antagonists
TargetsC-C chemokine receptor type 1
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUkraine +[8] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChemocentryx
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen Inc
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A